- Home
- CHSCP vs JSPRW Comparison
CHSCP vs JSPRW Comparison
Compare CHSCP & JSPRW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CHSCP
- JSPRW
- Stock Information
- Founded
- CHSCP N/A
- JSPRW N/A
- Country
- CHSCP United States
- JSPRW United States
- Employees
- CHSCP N/A
- JSPRW 45
- Industry
- CHSCP Farming/Seeds/Milling
- JSPRW Biotechnology: Pharmaceutical Preparations
- Sector
- CHSCP Industrials
- JSPRW Health Care
- Exchange
- CHSCP Nasdaq
- JSPRW Nasdaq
- Market Cap
- CHSCP N/A
- JSPRW N/A
- IPO Year
- CHSCP N/A
- JSPRW 2020
- Fundamental
- Price
- CHSCP $27.84
- JSPRW $0.23
- Analyst Decision
- CHSCP
- JSPRW
- Analyst Count
- CHSCP 0
- JSPRW 0
- Target Price
- CHSCP N/A
- JSPRW N/A
- AVG Volume (30 Days)
- CHSCP N/A
- JSPRW N/A
- Earning Date
- CHSCP N/A
- JSPRW N/A
- Dividend Yield
- CHSCP N/A
- JSPRW N/A
- EPS Growth
- CHSCP N/A
- JSPRW N/A
- EPS
- CHSCP N/A
- JSPRW N/A
- Revenue
- CHSCP N/A
- JSPRW N/A
- Revenue This Year
- CHSCP N/A
- JSPRW N/A
- Revenue Next Year
- CHSCP N/A
- JSPRW N/A
- P/E Ratio
- CHSCP N/A
- JSPRW N/A
- Revenue Growth
- CHSCP N/A
- JSPRW N/A
- 52 Week Low
- CHSCP N/A
- JSPRW N/A
- 52 Week High
- CHSCP N/A
- JSPRW N/A
- Technical
- Relative Strength Index (RSI)
- CHSCP 26.80
- JSPRW N/A
- Support Level
- CHSCP $28.62
- JSPRW N/A
- Resistance Level
- CHSCP $28.61
- JSPRW N/A
- Average True Range (ATR)
- CHSCP 0.40
- JSPRW 0.00
- MACD
- CHSCP -0.03
- JSPRW 0.00
- Stochastic Oscillator
- CHSCP 8.14
- JSPRW 0.00
About CHSCP CHS Inc. 8% Cumulative Redeemable Preferred Stock
CHS Inc is an integrated agricultural enterprise, that provides grain, food and energy resources to businesses and consumers. Its Energy segment produces and provides wholesale distribution of petroleum products and transportation of those products. Its Ag segment, which is the key revenue driver, purchases and processes or resells grains and oilseeds; serves as a wholesaler and retailer of crop inputs; produces and markets ethanol. Its Nitrogen Production segment consists of equity method investment in CF Nitrogen, which entitles to the purchase of up to a specified quantity of granular urea and UAN annually from CF Nitrogen. Maximum revenue is generated from Ag segment.
About JSPRW Japer Therapeutics Inc.
Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy.